相关实验视频
Updated: Jul 26, 2025

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
用于癌症治疗的刺激响应性原药化学
Rupa Bargakshatriya1,2, Sumit Kumar Pramanik1,2
1CSIR-Central Salt and Marine Chemicals Research Institute, Gijubhai Badheka Marg, Bhavnagar, Gujarat, 364002, India.
代理药物通过在向瘤部位释放活性化合物来增强药物输送. 本综述探讨了光剂-药物合物和刺激-可切割链接剂,以改善癌症治疗和实时监测.
科学领域:
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
- 癌症治疗 癌症治疗
背景情况:
- 产物药物是无活性药物衍生物,在体内转化为活性形式.
- 前药物策略提高了生物可用性,向性,疗效和安全性.
- 代药在癌症治疗中特别有前途,扩大了治疗窗口.
研究的目的:
- 审查化物药物合物的最新进展,以实时监测药物输送.
- 在前药物设计中讨论刺激可切割的链接剂及其切割机制.
- 批判性地评估开发先进前药物的前景和挑战.
主要方法:
- 专注于对刺激有反应的药物载体链接,以实现有针对性的释放.
- 分析瘤微环境中的化学,物理或生物刺激.
- 对用于体内追踪药物输送的化物-药物合物的审查.
主要成果:
- 代理药物能够在瘤部位进行空间时间控制的药物释放.
- 光合允许实时监控药物输送和分发.
- 刺激可切割的链接器对于产药的受控激活至关重要.
结论:
- 产物药物为向癌症治疗和改善药物性能提供了显著的潜力.
- 开发新的刺激反应链接器是前药物发展的关键.
- 解决前药物开发中的挑战对于未来的临床转化至关重要.
更多相关视频
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
12:24Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Prodrugs
Prodrugs help overcome...
Treatment Resistant Cancers
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...